Money & Markets modules for Wednesday, Dec. 28
The National Association of Realtors releases its November pending-home sales data, and the International Council of Shopping Centers issues weekly index of retail chain sales. The Mortgage Bankers Association reports its weekly tally of mortgage applications.
Drugmaker Biogen rose after the Food and Drug Administration approved its drug Spinraza, the first treatment for a rare genetic disorder marked by progressive muscle weakness.
Check-in time for hotel stocks
Hotel chains are among the stocks poised to record big gains if President-elect Donald Trump enacts reforms that kick U.S. economic growth into high gear.
Seattle Genetics (SGEN)
Applied Materials (AMAT)
Toll Brothers (TOL)
WEC Energy (WEC)
DFA Two-Year Global Fixed-Income (DFGFX)
This "Bronze" rated bond fund invests in AA or higher securities, and its exposure to U.S. assets and corporate bonds is higher than its peers' average. The strategy delivers "robust downside protection," Morningstar says.
For questions about Money & Markets modules, please contact Greg Keller (212-621-7958). For technical support: contact Todd Balog (816-654-1096). After 6 p.m., contact the AP Business News desk (800-845-8450, ext. 1680) for content questions; 1-800-3AP-STOX for technical support and 212-621-1905 for graphics help. The Money & Markets digest can also be found at www.markets.ap.org.